Pentavac, Poudre et suspension pour suspension injectable

7680006130012 CH-613 Puder
Pentavac, Poudre et suspension pour suspension injectable
Pentavac, Poudre et suspension pour suspension injectable
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Puder
Galenic group
Spray/Puder

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
07/05/2024
Summary of Product Characteristics
Français
07/05/2024
Summary of Product Characteristics
Italien
07/05/2024

Detailed composition

Substance Quantity Type Category
toxoidum diphtheriae
- Substance Wirkstoff (Principe actif)
polysaccharida haemophili influenzae typus B 1482 conjugata cum toxoido tetani
10.0 UG Substance Wirkstoff (Principe actif)
trometamolum
- Substance HNIDK
toxoidum tetani
- Substance Wirkstoff (Principe actif)
saccharum
- Substance HNIDK
bordetellae pertussis antigenum
- Substance Wirkstoff (Principe actif)
toxoidum pertussis
25.0 UG Substance WIIS
acidum hydrochloridum
- Substance HNIDK
haemagglutininum filamentosum
25.0 UG Substance WIIS
virus poliomyelitis typus 1 inactivatus
29.0 U Substance Wirkstoff (Principe actif)
virus poliomyelitis typus 2 inactivatus
7.0 U Substance Wirkstoff (Principe actif)
virus poliomyelitis typus 3 inactivatus
26.0 U Substance Wirkstoff (Principe actif)
aluminium
0.3 MG Substance HNIDK
aluminii hydroxidum hydricum ad adsorptionem
- Substance HNIDK
formaldehydum
- Substance HNIDK
medium 199
- Substance HNIDK
phenylalaninum
12.5 UG Substance HBESI
kalium
- Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
phenoxyethanolum
- Substance Konservierungsstoff (Conservateur)
ethanolum anhydricum
2.0 MG Substance HBESI
aqua ad iniectabile
- Substance HNIDK
neomycinum
- Substance HIMDK
streptomycinum
- Substance HIMDK
polymyxinum B
- Substance Wirkstoff (Principe actif)

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
613
Drug name
Pentavac, Poudre et suspension pour suspension injectable
Galenic form
PULSIN
ATC Code
J07CA06
Authorization status
Revoked/Withdrawn
Dispensing category
B
First authorization
18/08/1999
Authorization expiration date
01/04/2026
IT Number
08.08.
Domain
Human medicine
Field of application
ab dem vollendeten 2. bis zum vollendeten 24. Lebensmonat, aktive Immunisierung gegen Diphtherie, Tetanus, Pertussis, Poliomyelitisund Haemophilus influenzae Ty b

Package details

Description (FR)
PENTAVAC sub sèche+susp+aiguilles ser pré
Description (DE)
PENTAVAC Trockensub+Susp+Nadeln Fertspr
Market launch
18/08/1999
Market withdrawal
01/04/2026
Narcotic (BTM)
No

Application methods

IMU

Other package sizes (1)

PENTAVAC sub sèche+susp+aiguilles ser pré 10 pce
None None
GTIN: 7680006130029
Not in V1
Buy us a coffee Explore the data